SR1001 is primarily used in research settings for its role in modulating immune responses. It acts as a synthetic agonist for retinoid-related orphan receptors RORγ and RORα, which are involved in the differentiation and function of T helper 17 (Th17) cells. Due to this activity, SR1001 is studied for its potential in treating autoimmune and inflammatory diseases such as multiple sclerosis, psoriasis, and rheumatoid arthritis. By suppressing the production of pro-inflammatory cytokines like IL-17, it helps reduce inflammation in preclinical models. Its application remains experimental and is not approved for clinical use, but it serves as a valuable tool compound in immunology and drug discovery.